Christian W Keller Selected Research

Christian W Keller Research Topics

Disease

5	Multiple Sclerosis 11/2021 - 02/2016
5	Inflammation (Inflammations) 01/2018 - 02/2011
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 02/2016
4	Neoplasms (Cancer) 01/2020 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 11/2015
3	Neuroinflammatory Diseases 01/2021 - 02/2016
2	Relapsing-Remitting Multiple Sclerosis 01/2020 - 12/2019
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2019 - 01/2016
2	Polyneuropathies (Polyneuropathy) 01/2019 - 11/2015
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2017 - 02/2011
1	Demyelinating Diseases (Demyelinating Disease) 12/2021
1	Myasthenia Gravis 05/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Primary angiitis of the central nervous system 01/2021
1	Central Nervous System Vasculitis 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Lymphoma (Lymphomas) 12/2019
1	Disease Progression 01/2019
1	Infections 06/2017
1	Communicable Diseases (Infectious Diseases) 06/2017
1	Peripheral Nerve Injuries 01/2016
1	Rhabdomyosarcoma 02/2013
1	Inclusion Body Myositis 02/2011
1	Muscular Diseases (Myopathy) 02/2011

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 11/2021 - 06/2017
4	AntibodiesIBA 05/2021 - 01/2017
4	Immunoglobulin G (IgG)IBA 05/2021 - 11/2015
4	Complement System Proteins (Complement)IBA 01/2021 - 01/2016
3	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 02/2016
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2021 - 01/2021
2	Histocompatibility Antigens Class IIIBA 01/2021 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019 - 01/2016
1	Cholinergic ReceptorsIBA 05/2021
1	Fc Receptors (Fc Receptor)IBA 05/2021
1	cytochrome b245IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	InterferonsIBA 01/2021
1	InterleukinsIBA 01/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	OvalbuminIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	PhosphatidylserinesIBA 01/2021
1	IntegrinsIBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	Complement Factor H (Factor H)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Leukocyte Common Antigens (CD45 Antigen)IBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Green Fluorescent ProteinsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	InflammasomesIBA 01/2020
1	PyrinIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	LipopolysaccharidesIBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 12/2019
1	Alemtuzumab (Campath)FDA Link 12/2019
1	IceIBA 01/2019
1	AlbuminsIBA 01/2019
1	GlycolipidsIBA 06/2017
1	CytokinesIBA 06/2017
1	CD1d AntigensIBA 06/2017
1	AnaphylatoxinsIBA 01/2016
1	Monoclonal AntibodiesIBA 11/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2015
1	Immunoglobulin Fc FragmentsIBA 11/2015
1	Amyloid (Amyloid Fibrils)IBA 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011

Therapy/Procedure

3	Therapeutics 05/2021 - 01/2017
2	Immunotherapy 06/2017 - 01/2017
1	Organ Transplantation 01/2020
1	Plasmapheresis 01/2016